sec filing
XF
NASDAQ · XFOR
X4 Pharmaceuticals, Inc.
Healthcare · Biotechnology
$3.35
Down-$0.03 (-0.75%)
Updated Nov 2, 2026, 5:27 PM
SID Score
3.8/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 44.21M
- P/E ratio
- -0.28
- Dividend yield
- 0.00%
- 52-week range
- $2.43 – $4.83
- Volume
- 706.24K
- Avg. volume
- 894.59K
Price performance · XFOR
XFOR price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 30, 2026
XFOR closed at $3.35 after 20 trading sessions, up 15.52% for the selected period.
- Last close
- $3.35
- Period change
- +15.52%
- Period low
- $2.45
- Period high
- $3.36
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 30, 2026 | $3.33 | $3.41 | $3.19 | $3.35 | 706.24K |
| Oct 29, 2026 | $3.39 | $3.49 | $3.05 | $3.36 | 911.23K |
| Oct 28, 2026 | $3.24 | $3.36 | $3.14 | $3.35 | 534.95K |
| Oct 27, 2026 | $3.25 | $3.30 | $3.05 | $3.25 | 1.61M |
| Oct 26, 2026 | $3.26 | $3.30 | $3.14 | $3.25 | 701.65K |
| Oct 23, 2026 | $3.16 | $3.25 | $3.02 | $3.24 | 536.76K |
| Oct 22, 2026 | $2.99 | $3.2798 | $2.96 | $3.20 | 594.59K |
| Oct 21, 2026 | $3.02 | $3.12 | $2.875 | $3.01 | 406.91K |
| Oct 20, 2026 | $2.79 | $3.07 | $2.77 | $3.02 | 593.33K |
| Oct 19, 2026 | $2.60 | $2.82 | $2.58 | $2.75 | 602.98K |
| Oct 16, 2026 | $2.64 | $2.71 | $2.52 | $2.59 | 967.58K |
| Oct 15, 2026 | $2.48 | $2.655 | $2.475 | $2.64 | 549.84K |
| Oct 14, 2026 | $2.54 | $2.55 | $2.43 | $2.45 | 705.74K |
| Oct 13, 2026 | $2.81 | $2.83 | $2.59 | $2.60 | 439.6K |
| Oct 12, 2026 | $2.89 | $2.93 | $2.81 | $2.82 | 404.69K |
| Oct 9, 2026 | $2.83 | $2.965 | $2.815 | $2.91 | 541.23K |
| Oct 8, 2026 | $2.77 | $2.81 | $2.70 | $2.79 | 836.5K |
| Oct 7, 2026 | $2.74 | $2.86 | $2.70 | $2.81 | 435.38K |
| Oct 6, 2026 | $2.90 | $2.90 | $2.70 | $2.77 | 642.47K |
| Oct 5, 2026 | $2.88 | $2.935 | $2.73 | $2.90 | 698.1K |
Latest XFOR news
The latest Smart Investors Daily articles mentioning XFOR.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…

